Brca2em1Mjn
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Brca2em1Mjn |
| Name: |
breast cancer 2, early onset; endonuclease-mediated mutation 1, Maria Jasin |
| MGI ID: |
MGI:7641727 |
| Synonyms: |
Brca2S3214A, Brca2SA |
| Gene: |
Brca2 Location: Chr5:150446095-150493794 bp, + strand Genetic Position: Chr5, 89.52 cM
|
| Alliance: |
Brca2em1Mjn page
|
|
| Strain of Origin: |
Not Applicable
|
|
| Allele Type: |
|
Endonuclease-mediated (Not Applicable) |
| Mutation: |
|
Single point mutation
|
| |
|
Mutation details: Serine codon 3214 (TCT) in exon 27 was changed to alanine (GCT) (p.S3214A) using TALENs. The mutation disrupts the C-terminal RAD51 interaction site of the encoded peptide but doesn't affect its homology-directed repair function.
(J:346092)
|
|
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Brca2 Mutation: |
131 strains or lines available
|
|
| Original: |
J:346092 Lim PX, et al., BRCA2 promotes genomic integrity and therapy resistance primarily through its role in homology-directed repair. Mol Cell. 2024 Feb 1;84(3):447-462.e10 |
| All: |
2 reference(s) |
|